Ultralife Corporation

NASDAQ:ULBI

7.45 (USD) • At close December 31, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998199719961995199419931992
Revenue 158.644131.8498.267107.712106.79587.1985.53182.4676.42766.49478.835101.657139.386178.577172.109254.7137.59693.54670.50198.18279.4532.51524.16324.51421.116.415.915.114.65.33.91.5
Cost of Revenue 119.444102.4473.62578.55375.6361.60759.29957.35253.11147.14456.21472.927103.993132.008135.249197.757108.82276.10358.24377.8862.35431.16827.69623.47416.813.113.812.512.24.62.91.8
Gross Profit 39.229.424.64229.15931.16525.58326.23225.10823.31619.3522.62128.7335.39346.56936.8656.94328.77417.44312.25820.30217.0961.347-3.5331.044.33.32.12.62.40.71-0.3
Gross Profit Ratio 0.2470.2230.2510.2710.2920.2930.3070.3040.3050.2910.2870.2830.2540.2610.2140.2240.2090.1860.1740.2070.2150.041-0.1460.0420.2040.2010.1320.1720.1640.1320.256-0.2
Reseach & Development Expenses 7.5317.0816.8265.9476.8054.5084.7375.9465.6035.3335.8597.2168.5958.8179.548.13875.0973.7512.6332.5054.2913.4245.3065.96.73.900000
General & Administrative Expenses 000000015.36714.17415.41717.27221.0900000000000000000000
Selling & Marketing Expenses 00000000.0320.0590.0430.1140.53800000000000000000000
SG&A 22.19422.1917.78117.51116.99214.5215.01915.39914.23315.4617.38621.62824.32329.8434.68231.521.97315.30311.40910.7718.617.9498.0097.3856.25.85.28.774.42.21.6
Other Expenses 0-0.575-0.186-0.271-0.5970.058-0.181-0.1830.065-0.154-0.026-0.02400000001.803014.31802.0382.21.40.80.80.60.30.20.2
Operating Expenses 29.72529.27124.60723.45823.79719.02819.75621.34519.83620.79323.24528.84432.91838.65744.22239.63828.97320.415.1615.20711.11526.55811.43314.72914.313.99.99.57.64.72.41.8
Operating Income 9.475-4.33-3.5041.1734.6236.5556.4763.7633.33-1.443-0.624-0.1142.475-5.881-7.36217.305-0.199-2.957-2.9025.0955.981-25.211-14.966-13.689-10-10.6-7.8-6.9-5.2-4-1.4-2.1
Operating Income Ratio 0.06-0.033-0.0360.0110.0430.0750.0760.0460.044-0.022-0.008-0.0010.018-0.033-0.0430.068-0.001-0.032-0.0410.0520.075-0.775-0.619-0.558-0.474-0.646-0.491-0.457-0.356-0.755-0.359-1.4
Total Other Income Expenses Net -0.358-0.575-0.1861.322-0.5970.058-0.181-0.183-0.18-0.359-0.225-0.46-0.383-18.741-1.4780.2375.859-0.796-0.954-3.8670.5720.0297.949-2.2965.2892.93.54.43.423.20.4
Income Before Tax 9.117-0.446-0.1517.0236.7716.6136.2953.583.15-1.802-0.849-0.5742.092-6.879-8.8417.5425.66-3.753-3.8561.2286.553-25.182-17.262-11.151-8.4-7.1-7.1-3.4-3.5-3.2-0.8-1.7
Income Before Tax Ratio 0.057-0.003-0.0020.0650.0630.0760.0740.0430.041-0.027-0.011-0.0060.015-0.039-0.0510.0690.041-0.04-0.0550.0130.082-0.774-0.714-0.455-0.398-0.433-0.447-0.225-0.24-0.604-0.205-1.133
Income Tax Expense 1.951-0.3260.0791.6921.457-18.386-1.3690.0980.310.2680.2390.5540.528-0.670.3913.8790.07723.7350.489-21.1040.10613.9694.758-5.985-4.5-7.1-1.3-7.2-3.5-1.7-1.2-0.8
Net Income 7.197-0.12-0.235.2325.20524.937.6483.5092.869-2.116-0.926-1.598-2.08-6.179-9.24113.6635.583-27.488-4.34522.3326.447-25.182-17.262-10.242-7.1-7-7.2-3.2-3.4-3.1-0.8-1.7
Net Income Ratio 0.045-0.001-0.0020.0490.0490.2860.0890.0430.038-0.032-0.012-0.016-0.015-0.035-0.0540.0540.041-0.294-0.0620.2270.081-0.774-0.714-0.418-0.336-0.427-0.453-0.212-0.233-0.585-0.205-1.133
EPS 0.44-0.007-0.0140.330.331.570.490.230.18-0.12-0.053-0.092-0.12-0.36-0.540.790.36-1.84-0.31.590.49-2.03-1.55-0.94-0.68-0.84-0.91-0.41-0.5-0.57-0.2-0.63
EPS Diluted 0.44-0.007-0.0140.330.321.530.480.230.17-0.12-0.053-0.092-0.12-0.36-0.540.780.36-1.84-0.31.480.46-2.03-1.55-0.94-0.68-0.84-0.91-0.41-0.5-0.57-0.2-0.63
EBITDA 15.0444.5884.0498.63610.3778.9248.9036.7886.116-1.279-0.2090.3636.90716.529-1.62124.4415.9791.9090.2798.4049.114-6.948-20.946-11.155-11.651-7.8-9.2-7-6.1-4.6-3.7-1.2
EBITDA Ratio 0.0950.00100.0380.0690.0750.0760.0460.046-0.024-0.008-0.0010.0180.044-0.0430.087-0.0150.0150.0080.1380.101-0.214-0.36-0.579-0.445-0.774-0.484-0.636-0.432-0.849-0.462-1.533